Protalix BioTherapeutics ... (PLX)
NYSE American: PLX
· Real-Time Price · USD
2.22
-0.14 (-5.93%)
At close: Aug 14, 2026, 3:59 PM
2.22
+0.00%
After-hours: 7:56 PM
Protalix BioTherapeutics Inc. (PLX) Stock Price, Analysis & Data
-5.93% (1D)
| Bid | 2.22 |
| Market Cap | 178.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 9.65 |
| Forward PE | 3.58 |
| P/B (ttm) | 2.66 |
| P/S (ttm) | n/a |
| Earnings Date | Aug 14, 2025 |
| Ask | 2.27 |
| Volume | 990,071 |
| Avg. Volume (20D) | 698,659 |
| Open | 2.36 |
| Previous Close | 2.36 |
| Day's Range | 2.17 - 2.34 |
| 52-Week Range | 1.47 - 3.19 |
| Analyst | Strong Buy |
| Price Target | 11 (395.50%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PLX
A detailed description of the company is not yet available....
Industry n/a
Sector n/a
IPO Date May 15, 1998
Employees n/a
Stock Exchange NYSE American
Ticker Symbol PLX
Financial Performance
In 2025, Protalix BioTherapeutics's revenue was 52.74M, a decrease of -1.23% compared to the previous year's 53.4M. Earnings were -6.6M, a decrease of -325.24%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for PLX stock is "Strong Buy". The 12-month stock price forecast is 11, which is upside of 395.5% from the latest price.
Stock ForecastsEarnings Surprise
Protalix BioTherapeutics has released their quarterly earnings on Aug 12, 2026:
Protalix BioTherapeutics Inc. is scheduled to release its earnings on Aug 14, 2025, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2